뒤로
CellaVision AB(CVLLY) 가격
CVLLY 주가 차트
CVLLY 수입
CellaVision AB
CN¥0
0%
$0
종가: Jan 16, 16:00:00 GMT-5
CN¥0
0%
$0
애프터마켓: Jan 16, 20:00:00 GMT-5
최신 수익 결과: Q3 '25
보고됨: 2025-11-06
역사적 수익
분기별
연간
EPS
수익
Earnings FAQ
CVLLY의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
CellaVision AB CVLLY의 지난 분기 매출 실적은 어땠나요?
CellaVision AB의 매출 추정치는 얼마인가요?
CellaVision AB의 수익 품질 점수는 얼마인가요?
CellaVision AB는 언제 수익을 보고하나요?
CellaVision AB의 예상 수익은 얼마인가요?
CellaVision AB은 수익 기대치를 충족했나요?
주요 통계
이전 종가
--
시가
--
일일 범위
-
52주 범위
-
거래량
--
평균 거래량
--
EPS(TTM)
--
배당수익률
--
시가총액
--
CVLLY란 무엇인가요?
CellaVision AB engages in the provision of digital microscopy solutions for hematology laboratories. The company is headquartered in Lund, Skane and currently employs 230 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.